Indivior Pharmaceuticals (INDV) Cash from Operations (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Cash from Operations of 9000000.0 for Q1 2026, down 112.0% year-over-year from 75000000.0 in Q1 2025, and up 95.93% quarter-over-quarter from 221000000.0 in Q4 2025.
Indivior Pharmaceuticals (INDV) Cash from Operations (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Cash from Operations history runs 3 years deep, the most recent figure standing at 9000000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 112.0% year-over-year to 9000000.0; the TTM figure through Mar 2026 stood at 111000000.0 (down 175.0% YoY), while the FY2025 annual figure was 27000000.0, down 175.0% from the prior year.
- Cash from Operations for Q1 2026 stood at 9000000.0, up from 221000000.0 in the prior quarter.
- The five-year high for Cash from Operations was 158000000.0 in Q2 2025, with the low at 221000000.0 in Q4 2025.
- The 3-year median for Cash from Operations is 9000000.0 (2026), against an average of 0.0.
- Peak annual rise in Cash from Operations reached 302.7% in 2025, while the deepest fall reached 2050.0% in 2025.
- Indivior Pharmaceuticals' Cash from Operations stood at 17000000.0 in 2024, then plunged by 1200.0% to 221000000.0 in 2025, then surged by 95.93% to 9000000.0 in 2026.
- Business Quant data shows INDV's Cash from Operations at 9000000.0 in Q1 2026, 221000000.0 in Q4 2025, and 39000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | 229.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 229.00 Mn |
| Jun 30, 2026 | 229.00 Mn |
| Mar 31, 2026 | -9.00 Mn |
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | -221.00 Mn |
| Dec 31, 2025 | -221.00 Mn |
| Sep 30, 2025 | -39.00 Mn |
| Sep 30, 2025 | -39.00 Mn |
| Jun 30, 2025 | 158.00 Mn |
| Jun 30, 2025 | 158.00 Mn |
| Mar 31, 2025 | 75.00 Mn |
| Mar 31, 2025 | 75.00 Mn |
| Dec 31, 2024 | -17.00 Mn |
| Dec 31, 2024 | -17.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 88.00 Mn |
| Jun 30, 2024 | 88.00 Mn |
| Mar 31, 2024 | -37.00 Mn |
| Mar 31, 2024 | -37.00 Mn |